<unk>  is a proteolytic enzyme that is FDA approved for the treatment of symptomatic vitreomacular adhesion.   Common adverse reactions include blurred vision, conjunctival hemorrhage, macular hole, pain in eye, photopsia, retinal edema, uveitis, visual impairment, vitreous floaters.
Ocriplasmin
Anistreplase
Antithrombin III
Coagulation factor VIIa
Recombinant factor VIIa
Factor XIII concentrate
Prothrombin complex concentrate
Hirudin